SCHEMBL13301073

SCHEMBL13301073

CCOC(=O)CSCCC[Si](C)(C)OCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
TRPA1 O75762 1/20 0.37
LMNA P02545 3/20 0.36
HTT P42858 2/20 0.36
CSNK2A2 P19784 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
GAA P10253 3/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
HSD17B10 Q99714 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
RAB9A P51151 1/20 0.35
TSHR P16473 1/20 0.35
CYP1A2 P05177 3/20 0.34
CYP2C9 P11712 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10179014 0.85 ALDH1A1 (0.39) ALDH1A1LMNACSNK2A2CSNK2BCSNK2A1
SCHEMBL3334466 0.83 GMNN (0.50) ALDH1A1HSD17B10SMN1; SMN2TSHRCYP2C9
SCHEMBL16260974 0.79 CA12 (0.35) ALDH1A1TRPA1
SCHEMBL15977058 0.78
SCHEMBL770514 0.78 ALDH1A1 (0.39) ALDH1A1
SCHEMBL18094961 0.78 CYP1A2 (0.52) ALDH1A1TRPA1LMNAGAAMGAM
SCHEMBL1710113 0.77 CES1 (0.50) ALDH1A1TRPA1LMNAHTTGAA
SCHEMBL20841661 0.76 MGAM (0.52) ALDH1A1TRPA1LMNAHTTGAA
SCHEMBL11328942 0.75 CES2 (0.57) ALDH1A1TRPA1HTTGAAMGAM
SCHEMBL14643394 0.75 CYP1A2 (0.53) ALDH1A1TRPA1LMNAHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100145089-A1 PREPARATION OF (POLY)SULFIDE ALKOXYSILANES AND NOVEL INTERMEDIATES THEREFOR RHODIA OPERATIONS (FR) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145089-A1 PREPARATION OF (POLY)SULFIDE ALKOXYSILANES AND NOVEL INTERMEDIATES THEREFOR TST, CTH, CBS ALDH1A1 1885/4885TRPA1 780/4885LMNA 4645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.